Purdue researcher awarded $1.3 million for malaria drug trials in Southeast Asia and Africa
Philip Low looks to validate previous trial results and test whether the number of days of an anti-malaria drug therapy can be reduced WEST LAFAYETTE, Ind., Sept. 15, 2023 (GLOBE NEWSWIRE) — A Purdue researcher